Just Biotherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Just Biotherapeutics's estimated annual revenue is currently $126.1M per year.
- Just Biotherapeutics received $14.0M in venture funding in July 2016.
- Just Biotherapeutics's estimated revenue per employee is $217,000
- Just Biotherapeutics's total funding is $29M.
Employee Data
- Just Biotherapeutics has 581 Employees.
- Just Biotherapeutics grew their employee count by 46% last year.
Just Biotherapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Just Biotherapeutics?
Just is an integrated design company focused on the technology of biotherapeutics, from molecule to manufacturing plant. We believe that technological innovation will accelerate biotherapeutic development and dramatically reduce the cost of these vital medicines.
keywords:Biotechnology,Healthcare,Pharmaceuticals
$29M
Total Funding
581
Number of Employees
$126.1M
Revenue (est)
46%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Just Biotherapeutics News
Satellite Bio lifts off with $110M to fuel development of its implantable ... with just one other asset, ADMIR, in the formulation stage.
Arcutis Biotherapeutics finds psoriasis isn't just skin deep, with Harris Poll also pointing to a gap in provider communication.
CODA CSO Susan Catalano, Ph.D./courtesy of CODA Biotherapeutics ... D.C.) The whole thing is about 335 miles long and is just gorgeous!
German drug discovery company Evotec — which has a robust rolodex of biopharma partners such as Bayer, Boehringer Ingelheim, Celgene, Novartis, Novo Nordisk, Pfizer, Sanofi and Takeda — is acquiring Just Biotherapeutics, a Seattle-based company focused on reducing t ...
Hangzhou Just Biotherapeutics, Ltd., a Shanghai, China-based developer of global antibody and recombinant protein biotherapeutics, raised 35m in Series B+ financing round. The round, which brings total funding to over $120m so far, was led by Hillhouse Capital (Hillhouse), a Beijing and Hong Ko ...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $153M | 583 | 6% | N/A |
#2 | $236.2M | 585 | 1% | N/A |
#3 | $161.2M | 586 | 6% | N/A |
#4 | $103.1M | 589 | 1% | N/A |
#5 | $187.6M | 591 | 53% | N/A |
Just Biotherapeutics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2015-09-22 | $15.0M | A | Merck | Article |
| 2016-07-26 | $14.0M | A2 | The Bill & Melinda Gates Foundation | Article |